Invesco Charter R holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Invesco Charter Fund Class R CHRRX
- NAV / 1-Day Return 22.34 / −0.49 %
- Total Assets 3.8B
-
Adj. Expense Ratio
1.260%
- Expense Ratio 1.260%
- Distribution Fee Level Above Average
- Share Class Type Retirement, Medium
- Category Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 36%
USD | NAV as of Jun 17, 2026 | 1-Day Return as of Jun 17, 2026, 12:11 AM GMT+0
Morningstar’s Analysis CHRRX
Will CHRRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the CHRRX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of CHRRX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 45.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
NVIDIA Corp | 8.56 | 314M | Technology |
Alphabet Inc Class A | 7.42 | 272M | Communication Services |
Microsoft Corp | 5.91 | 217M | Technology |
Apple Inc | 5.53 | 203M | Technology |
Amazon.com Inc | 4.73 | 174M | Consumer Cyclical |
Broadcom Inc | 4.10 | 150M | Technology |
Meta Platforms Inc Class A | 2.93 | 108M | Communication Services |
JPMorgan Chase & Co | 2.59 | 95M | Financial Services |
Advanced Micro Devices Inc | 1.82 | 67M | Technology |
Eli Lilly and Co | 1.71 | 63M | Healthcare |
United States